Kiadis Pharma NV (Kiadis Pharma NV) Buildings And Improvements : $12.26 Mil (As of Dec. 2020)

View and export this data going back to 2016. Start your Free Trial

What is Kiadis Pharma NV Buildings And Improvements?

Kiadis Pharma NV's quarterly buildings and improvements declined from Dec. 2019 ($11.78 Mil) to Jun. 2020 ($11.04 Mil) but then increased from Jun. 2020 ($11.04 Mil) to Dec. 2020 ($12.26 Mil).

Kiadis Pharma NV's annual buildings and improvements increased from Dec. 2018 ($8.29 Mil) to Dec. 2019 ($11.78 Mil) and increased from Dec. 2019 ($11.78 Mil) to Dec. 2020 ($12.26 Mil).

Kiadis Pharma NV Buildings And Improvements Historical Data

The historical data trend for Kiadis Pharma NV's Buildings And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kiadis Pharma NV Buildings And Improvements Chart

Kiadis Pharma NV Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Buildings And Improvements

Get a 7-Day Free Trial

0.08

0.12

8.29

11.78

12.26

Kiadis Pharma NV Semi-Annual Data
	Dec12	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20
Buildings And Improvements	Get a 7-Day Free Trial											8.29	12.71	11.78	11.04	12.26

Kiadis Pharma NV Buildings And Improvements Calculation

Buildings are typically valued at the time of acquisition or construction. Broker and architect fees, permits, etc. can be covered within this category. Building components, such as a roof, are normally recorded separately in an asset register since the value and useful lives of these components equal much less than the building itself.

Building improvements that extend the useful life of a building will fall into the category of “building improvements” and should be capitalized. Improvements are commonly recorded at acquisition cost. Building improvement examples include roofing, remodeling, replacements, etc.

Kiadis Pharma NV (Kiadis Pharma NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Kiadis Pharma NV (GREY:KIADF) » Definitions » Buildings And Improvements

Comparable Companies

Traded in Other Exchanges

N/A

Address

Paasheuvelweg 25A, Amsterdam, NLD, 1105 BP

Website

https://www.kiadis.com

Kiadis Pharma NV is a Netherlands based clinical-stage biopharmaceutical company. It is focused on research, development, and commercialization of cell-based immunotherapy products for the treatment of blood cancers and inherited blood disorders. The company's product pipeline includes K-NK002, K-NK003, K-NK00X, and others.

Kiadis Pharma NV (Kiadis Pharma NV) Headlines

No Headlines